Cite
Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin in Subclinical Atherosclerosis—The Rationale and Methodology of the METEOR Study
MLA
Gregory W. Evans, et al. “Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin in Subclinical Atherosclerosis—The Rationale and Methodology of the METEOR Study.” Cardiovascular Drugs and Therapy, vol. 18, May 2004, pp. 231–38. EBSCOhost, https://doi.org/10.1023/b:card.0000033645.55138.3d.
APA
Gregory W. Evans, Diederick E. Grobbee, Ward A. Riley, Michiel L. Bots, Joel S. Raichlen, Mike K. Palmer, Daniel H. O’Leary, & John R. Crouse. (2004). Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin in Subclinical Atherosclerosis—The Rationale and Methodology of the METEOR Study. Cardiovascular Drugs and Therapy, 18, 231–238. https://doi.org/10.1023/b:card.0000033645.55138.3d
Chicago
Gregory W. Evans, Diederick E. Grobbee, Ward A. Riley, Michiel L. Bots, Joel S. Raichlen, Mike K. Palmer, Daniel H. O’Leary, and John R. Crouse. 2004. “Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin in Subclinical Atherosclerosis—The Rationale and Methodology of the METEOR Study.” Cardiovascular Drugs and Therapy 18 (May): 231–38. doi:10.1023/b:card.0000033645.55138.3d.